344 related articles for article (PubMed ID: 15585990)
21. Overview of the pharmacological spasm provocation test: Comparisons between acetylcholine and ergonovine.
Sueda S; Kohno H; Ochi T; Uraoka T; Tsunemitsu K
J Cardiol; 2017 Jan; 69(1):57-65. PubMed ID: 27856130
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of accelerated exercise following mild hyperventilation for the induction of coronary artery spasm : comparison with an acetylcholine Test.
Sueda S; Fukuda H; Watanabe K; Ochi N; Kawada H; Hayashi Y; Uraoka T
Chest; 2001 Jan; 119(1):155-62. PubMed ID: 11157598
[TBL] [Abstract][Full Text] [Related]
23. Overview of the Acetylcholine Spasm Provocation Test.
Sueda S; Kohno H; Ochi T; Uraoka T
Clin Cardiol; 2015 Jul; 38(7):430-8. PubMed ID: 26175183
[TBL] [Abstract][Full Text] [Related]
24. Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecutive patients with coronary spasm: analysis of a single-center study over 20 years.
Sato K; Kaikita K; Nakayama N; Horio E; Yoshimura H; Ono T; Ohba K; Tsujita K; Kojima S; Tayama S; Hokimoto S; Matsui K; Sugiyama S; Yamabe H; Ogawa H
J Am Heart Assoc; 2013 Jul; 2(4):e000227. PubMed ID: 23858100
[TBL] [Abstract][Full Text] [Related]
25. Coincidence between spontaneous and inducible coronary spasm: acetylcholine test is clinically valued for diagnosing coronary spasm.
Sueda S; Sakaue T
Heart Vessels; 2021 Jun; 36(6):749-755. PubMed ID: 33389065
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcome according to spasm type of single coronary artery provoked by intracoronary ergonovine tests in patients without significant organic stenosis.
Kim DW; Her SH; Ahn Y; Shin DI; Han SH; Kim DS; Choi DJ; Kwon HM; Gwon HC; Jo SH; Rha SW; Baek SH
Int J Cardiol; 2018 Feb; 252():6-12. PubMed ID: 29249438
[TBL] [Abstract][Full Text] [Related]
27. Sex-related Differences in Patients with Positive Coronary Spasm as Identified by Acetylcholine Testing.
Sueda S; Sakaue T
Intern Med; 2021 Aug; 60(15):2357-2365. PubMed ID: 33583899
[TBL] [Abstract][Full Text] [Related]
28. What is the meaning of provoked spasm phenotypes by vasoreactivity testing?
Sueda S; Kurokawa K; Sakaue T; Ikeda S
J Cardiol; 2024 Jan; 83(1):1-7. PubMed ID: 37453595
[TBL] [Abstract][Full Text] [Related]
29. The effect of intracoronary administration of ergonovine on the contralateral coronary artery in a provocation test for the diagnosis of variant angina.
Kim JH; Kim C; Kim J; Park JS; Lee HW; Choi JH; Lee HC; Cha KS; Hong TJ; Oh JH
Acta Cardiol; 2014 Dec; 69(6):628-34. PubMed ID: 25643433
[TBL] [Abstract][Full Text] [Related]
30. Intracoronary Acetylcholine Provocation Testing - Omission of the 20-µg Dose Is Feasible in Patients Without Coronary Artery Spasm in the Other Coronary Artery.
Saito Y; Kitahara H; Shoji T; Tokimasa S; Nakayama T; Sugimoto K; Fujimoto Y; Kobayashi Y
Circ J; 2016 Jul; 80(8):1820-3. PubMed ID: 27350015
[TBL] [Abstract][Full Text] [Related]
31. Maximal acetylcholine dose of 200 μg into the left coronary artery as a spasm provocation test: comparison with 100 μg of acetylcholine.
Sueda S; Kohno H; Miyoshi T; Sakaue T; Sasaki Y; Habara H
Heart Vessels; 2015 Nov; 30(6):771-8. PubMed ID: 25179297
[TBL] [Abstract][Full Text] [Related]
32. Safety of intracoronary provocative testing for the diagnosis of coronary artery spasm.
Ciliberti G; Seshasai SRK; Ambrosio G; Kaski JC
Int J Cardiol; 2017 Oct; 244():77-83. PubMed ID: 28622945
[TBL] [Abstract][Full Text] [Related]
33. Intra-brachial ergonovine, not acetylcholine, is associated with radial artery vasospasm in patients with coronary vasospasm.
Wu YY; Mao WW; Li YF; Zhang Q; Zhang B; Sheng ZQ
Acta Cardiol; 2023 Feb; 78(1):135-141. PubMed ID: 35899777
[TBL] [Abstract][Full Text] [Related]
34. Relationships between more than 90% coronary luminal narrowing induced by ergonovine provocation test and ECG ischemic change as well as chest symptoms.
Sueda S; Kohno H
Heart Vessels; 2018 Feb; 33(2):95-101. PubMed ID: 28808762
[TBL] [Abstract][Full Text] [Related]
35. Impact of vasomotion type on prognosis of coronary artery spasm induced by acetylcholine provocation test of left coronary artery.
Lee EM; Choi MH; Seo HS; Kim HK; Kim NH; Choi CU; Kim JW; Lim HE; Kim EJ; Rha SW; Park CG; Oh DJ
Atherosclerosis; 2017 Feb; 257():195-200. PubMed ID: 28012648
[TBL] [Abstract][Full Text] [Related]
36. Transitional changes of acetylcholine spasm provocation test procedures.
Sueda S; Kohno H
Cardiovasc Interv Ther; 2020 Oct; 35(4):321-326. PubMed ID: 31641953
[TBL] [Abstract][Full Text] [Related]
37. Serious cardiac complications in coronary spasm provocation tests using acetylcholine or ergonovine: analysis of 21 512 patients from the diagnosis procedure combination database in Japan.
Isogai T; Yasunaga H; Matsui H; Tanaka H; Ueda T; Horiguchi H; Fushimi K
Clin Cardiol; 2015 Mar; 38(3):171-7. PubMed ID: 25693967
[TBL] [Abstract][Full Text] [Related]
38. Increased basal tone and hyperresponsiveness to acetylcholine and ergonovine in spasm-related coronary arteries in patients with variant angina.
Lee SJ; Park SJ; Park SW; Kim JJ; Song JK; Hong MK; Kang DH; Cheong SS
Int J Cardiol; 1996 Jul; 55(2):117-26. PubMed ID: 8842780
[TBL] [Abstract][Full Text] [Related]
39. Spasm Provocation Tests under Medication May Help Decide on Medical or Mechanical Therapy in Patients with Aborted Sudden Cardiac Death due to Coronary Spasm.
Sueda S; Sakaue T; Okura T
Intern Med; 2020 Jun; 59(11):1351-1359. PubMed ID: 32132336
[TBL] [Abstract][Full Text] [Related]
40. Disparity between serotonin- and acetylcholine-provoked coronary artery spasm.
Kanazawa K; Suematsu M; Ishida T; Hirata K; Kawashima S; Akita H; Yokoyama M
Clin Cardiol; 1997 Feb; 20(2):146-52. PubMed ID: 9034644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
